VALEANT PHARMACEUTICALS INTERNATIONAL, INC. FILES (8-K) Disclosing Change in Directors or Principal Officers, Financial Statements and Exhibits

Edgar Glimpses |

Item 5.02 Departure of Directors or Certain Officers; Election of Directors;

           Appointment of Certain Officers; Compensatory Arrangements of Certain

On , the board of directors (the "Board") of Valeant Pharmaceuticals International, Inc. (the "Company") increased the number of directors of the Board from ten to eleven. In addition, on , upon the recommendation of the Nominating and Corporate Governance Committee of the Board, the Board appointed John A. Paulson a director of the Board. Mr. Paulson's current term as director will expire at the Company's 2018 annual shareholder meeting or upon his removal or resignation from the Board, whichever is earliest.

Mr. Paulson is the president of Paulson & Co., Inc., a New York-based investment firm.

Mr. Paulson will receive compensation as a non-employee director in accordance with the Company's non-employee director compensation practices, as described in the Company's Management Proxy Circular and Proxy Statement filed with the Securities and Exchange Commission on . There are no arrangements or understandings between Mr. Paulson and any other persons pursuant to which Mr. Paulson was selected as a director, and there have been no transactions since the beginning of the Company's last fiscal year, or are currently proposed, regarding Mr. Paulson that are required to be disclosed pursuant to Item 404(a) of Regulation S-K.

Mr. Paulson has not yet been named to any committees of the Board and, as of the date hereof, it has not been determined to which committees of the Board, if any, Mr. Paulson will be named.

A copy of the press release, dated , announcing the appointment of Mr. Paulson to the Board is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d)    Exhibits

Number                                Description

99.1 Press Release announcing the appointment of John A. Paulson to the Board

        of the Company, dated .


DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

CMX Gold & Silver Corp.

CMX Gold & Silver Corp is an exploration stage company. The Company is engaged in the acquisition, exploration and development of silver and copper/gold properties in the USA.

Private Markets

The Green Organic Dutchman

The Green Organic Dutchman Ltd. ("TGOD") produces farm grown, organic cannabis for medical use. The company grows its high quality organic cannabis in small batches using craft growing, all natural…


Voleo is a free download that allows you to form investment clubs with your friends, family, colleagues, classmates, teammates…basically anyone you know and trust. Invest and manage a stock portfolio…